Powered by Altman Clinical and Translational Research Institute
UCSD Profiles
search, discover, network
Home
About
Help/FAQs
History (0)
Search Options
UC Davis
UCI
UCLA
UCSD
UCSF
All UC Health
USC
All
Everything
Research
Concepts
Awards
People
UC Health People
UC Davis People
UCI People
UCLA People
UCSD People
UCSF People
USC People
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Shu Mei Kato
Concepts (289)
Back to Profile
Concepts are derived automatically from a person's publications.
Cloud
Categories
Timeline
Details
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
Adenocarcinoma
Administration, Oral
Adolescent
Adult
Aged
Aged, 80 and over
Albumins
Amino Acid Substitution
Animals
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antigens, CD
Antigens, Neoplasm
Antineoplastic Agents
Antineoplastic Agents, Immunological
Antineoplastic Combined Chemotherapy Protocols
Appendiceal Neoplasms
Aromatase Inhibitors
B7-H1 Antigen
beta Catenin
Bevacizumab
Bias
Bile Duct Neoplasms
Bile Ducts, Intrahepatic
Biliary Tract Neoplasms
Biomarkers
Biomarkers, Tumor
Biopsy
Bone Marrow
Bone Neoplasms
Boron Compounds
Brain Neoplasms
Breast Neoplasms
California
Carboplatin
Carcinogenesis
Carcinoma
Carcinoma, Basal Cell
Carcinoma, Neuroendocrine
Carcinoma, Non-Small-Cell Lung
Carcinoma, Pancreatic Ductal
Cell Cycle
Cell Cycle Proteins
Cell Differentiation
Cell Line, Tumor
Cell Proliferation
Cell Transformation, Neoplastic
Cell-Free Nucleic Acids
Chemoradiotherapy
Chick Embryo
Child
Child, Preschool
Cholangiocarcinoma
Chromatin
Chromosome Aberrations
Circulating Tumor DNA
Class I Phosphatidylinositol 3-Kinases
Clinical Decision-Making
Clinical Trials as Topic
Clinical Trials, Phase II as Topic
Clonal Evolution
Cluster Analysis
Codon
Cohort Studies
Colorectal Neoplasms
Combined Modality Therapy
Computational Biology
CTLA-4 Antigen
Cyclin D
Cyclin D1
Cyclin-Dependent Kinase 4
Cyclin-Dependent Kinase 6
Cyclin-Dependent Kinase Inhibitor p15
Cyclin-Dependent Kinase Inhibitor p16
Cyclin-Dependent Kinase Inhibitor p18
Cyclins
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Dasatinib
Databases, Genetic
Deoxycytidine
Disease Management
Disease Progression
Disease Susceptibility
Disease-Free Survival
DNA Copy Number Variations
DNA Helicases
DNA Mutational Analysis
DNA, Neoplasm
DNA-Binding Proteins
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Approval
Drug Resistance, Neoplasm
Early Detection of Cancer
Early Diagnosis
Enzyme Inhibitors
Epidermal Growth Factor
Epithelial Cells
Epithelial-Mesenchymal Transition
ErbB Receptors
Erdheim-Chester Disease
Erlotinib Hydrochloride
Esophageal Neoplasms
Esophagogastric Junction
Etodolac
Everolimus
False Positive Reactions
Feasibility Studies
Female
Fluorouracil
Follow-Up Studies
Fusion Proteins, bcr-abl
G1 Phase Cell Cycle Checkpoints
Galectin 3
Gastrointestinal Stromal Tumors
Gene Amplification
Gene Expression
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Gene Frequency
Gene Rearrangement
Gene Silencing
Genes, p16
Genes, ras
Genetic Predisposition to Disease
Genetic Testing
Genetic Variation
Genital Neoplasms, Female
Genome, Human
Genomics
Genotype
Germ-Line Mutation
Glioma
Glycine
GTP-Binding Protein alpha Subunits, Gq-G11
Guideline Adherence
High-Throughput Nucleotide Sequencing
Histiocytosis, Sinus
Histocompatibility Antigens Class I
Humans
Immunoenzyme Techniques
Immunohistochemistry
Immunologic Factors
Immunotherapy
Integrin alphaVbeta3
Integrin beta3
Intention to Treat Analysis
Janus Kinase 2
Kaplan-Meier Estimate
Leucovorin
Leukemia, Myeloid
Liquid Biopsy
Logistic Models
Lung Neoplasms
Lymphatic Metastasis
Male
Mammary Glands, Animal
MAP Kinase Kinase Kinases
MAP Kinase Signaling System
Maximum Tolerated Dose
Mechanistic Target of Rapamycin Complex 1
Medical Oncology
Melanoma
Mesothelioma
Mice
Mice, Inbred NOD
Mice, Nude
Mice, SCID
Microsatellite Instability
Middle Aged
Mitogen-Activated Protein Kinase Kinases
Mitogen-Activated Protein Kinases
Models, Biological
Molecular Targeted Therapy
Mucin-1
Multivariate Analysis
Mutation
MutS Homolog 2 Protein
Nectins
Neoplasm Grading
Neoplasm Invasiveness
Neoplasm Metastasis
Neoplasm Recurrence, Local
Neoplasm Staging
Neoplasms
Neoplasms, Unknown Primary
Neoplastic Stem Cells
Neurofibromin 1
Neurofibromin 2
NF-kappa B
Nitriles
Nuclear Proteins
Observational Studies as Topic
Oligonucleotide Array Sequence Analysis
Organoplatinum Compounds
Osteosarcoma
Ovarian Neoplasms
Paclitaxel
Pancreatic Neoplasms
Patient Selection
Peritoneal Neoplasms
Pharmacogenetics
Phenotype
Phosphatidylinositol 3-Kinases
Phthalazines
Piperazines
Poly(ADP-ribose) Polymerase Inhibitors
Polymerase Chain Reaction
Polymorphism, Genetic
Polymorphism, Single Nucleotide
Precancerous Conditions
Precision Medicine
Predictive Value of Tests
Pregnancy
Preoperative Period
Primary Myelofibrosis
Prognosis
Programmed Cell Death 1 Ligand 2 Protein
Programmed Cell Death 1 Receptor
Proportional Hazards Models
Prospective Studies
Prostatic Neoplasms
Prostatic Neoplasms, Castration-Resistant
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Proteomics
Proto-Oncogene Proteins
Proto-Oncogene Proteins B-raf
Proto-Oncogene Proteins c-kit
Proto-Oncogene Proteins c-mdm2
Proto-Oncogene Proteins c-rel
Proto-Oncogene Proteins p21(ras)
PTEN Phosphohydrolase
Pyridines
Quinazolines
Radiosurgery
ral GTP-Binding Proteins
Randomized Controlled Trials as Topic
ras Proteins
Receptor Protein-Tyrosine Kinases
Receptor, ErbB-2
Receptor, Fibroblast Growth Factor, Type 3
Receptor, Platelet-Derived Growth Factor alpha
Receptors, Estrogen
Receptors, Vitronectin
Research Design
Retinoid X Receptor alpha
Retreatment
Retrospective Studies
Risk Factors
RNA Interference
RNA, Neoplasm
Salivary Gland Neoplasms
Sequence Analysis, DNA
Signal Transduction
Skin
Skin Neoplasms
SMARCB1 Protein
Snail Family Transcription Factors
Spatio-Temporal Analysis
Spheroids, Cellular
src-Family Kinases
Stem Cells
Stomach
Stomach Neoplasms
Survival Analysis
Survival Rate
Tamoxifen
Time Factors
Tomography, X-Ray Computed
TOR Serine-Threonine Kinases
Transcription Factors
Transcriptome
Transfection
Transforming Growth Factor beta2
Treatment Failure
Treatment Outcome
Triazoles
Tumor Burden
Tumor Cells, Cultured
Tumor Microenvironment
Tumor Suppressor Protein p53
Uterine Cervical Neoplasms
Vaccination
Vascular Endothelial Growth Factor A
Whole Genome Sequencing
Xenograft Model Antitumor Assays
Young Adult
With one click, see people who:
Mentor Faculty
Run Clinical Trials
See more options in the
Advanced Search
tab
Shu Mei's Networks
Concepts (289)
Derived automatically from this person's publications.
Neoplasms
Neoplasms, Unknown Primary
Circulating Tumor DNA
Biomarkers, Tumor
Mitogen-Activated Protein Kinase Kinases
Explore
_
Co-Authors (60)
People in Profiles who have published with this person.
Sicklick, Jason
UCSD
Goodman, Aaron
UCSD
Lippman, Scott
UCSD
Fanta, Paul
UCSD
Cohen, Ezra
UCSD
Explore
_
Similar People (60)
People who share similar concepts with this person.
Lenz, Heinz-Josef
USC
Ribas, Antoni
UCLA
Hoffman, Robert
UCSD
Prasad, Vinayak
UCSF
Gandara, David
UC Davis
Explore
_
Same Department
Gordts, Philip
Jones, Oliver
Pandita, Pooja
Reeves, Ryan
Zhang, Lingzhi
Search Department
_